Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy
Published inAIDS, vol. 27, no. 2, p. 203-210
Publication date2013
Abstract
Keywords
- Amyloid beta-Peptides/cerebrospinal fluid/drug effects
- Antiretroviral Therapy, Highly Active/methods
- Astrocytes/drug effects
- Biological Markers/cerebrospinal fluid
- Enzyme-Linked Immunosorbent Assay
- HIV Infections/cerebrospinal fluid/drug therapy
- HIV Protease Inhibitors/therapeutic use
- Humans
- Lopinavir/therapeutic use
- Neopterin/cerebrospinal fluid
- Peptide Fragments/cerebrospinal fluid/drug effects
- Ritonavir/therapeutic use
- S100 Proteins/cerebrospinal fluid
- Switzerland
- Thailand
- Tau Proteins/cerebrospinal fluid/drug effects
Affiliation entities
Research groups
Citation (ISO format)
DU PASQUIER, Renaud Alfred Robert et al. Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy. In: AIDS, 2013, vol. 27, n° 2, p. 203–210. doi: 10.1097/QAD.0b013e32835a9a4a
Main files (1)
Article (Published version)
Identifiers
- PID : unige:74513
- DOI : 10.1097/QAD.0b013e32835a9a4a
- PMID : 23032410
Journal ISSN0269-9370
